Literature DB >> 16183482

Partial volume tolerance of the liver to radiation.

Laura A Dawson1, Randall K Ten Haken.   

Abstract

The use of conformal radiotherapy (RT) and the follow-up of patients for radiation liver toxicities has led to a quantitative understanding of partial liver RT tolerance. The most common toxicity is radiation-induced liver disease (RILD), a syndrome of anicteric ascites and hepatomegaly. Elevation of transaminases and reactivation of viral hepatitis have also been reported after liver RT. The Lyman normal tissue complication probability (NTCP) model and a local damage-organ injury NTCP model have been used to describe the partial tolerance of the liver to RT. The liver exhibits a large volume effect and a low threshold volume for RILD. The RT tolerance of the liver is reduced in patients with primary liver cancer versus metastases. Elevated transaminases are more common in the presence of poor liver function and hepatitis B infection. If the effective liver volume irradiated is less than 25%, very high RT doses may be delivered with little risk of liver toxicity. The mean liver doses associated with a 5% risk of classic RILD for primary and metastatic liver cancer are 28 Gy and 32 Gy, respectively, in 2 Gy per fraction.

Entities:  

Mesh:

Year:  2005        PMID: 16183482     DOI: 10.1016/j.semradonc.2005.04.005

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  71 in total

1.  MRI morphologic alterations after liver SBRT : Direct dose correlation with intermodal matching.

Authors:  Judit Boda-Heggemann; Ulrike Attenberger; Johannes Budjan; Anika Jahnke; Lennart Jahnke; Lena Vogel; Anna O Simeonova-Chergou; Carsten Herskind; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2016-07-08       Impact factor: 3.621

2.  Liver regeneration following repeat SBRT.

Authors:  Andrew Farach; Jorge Quesada; Bin S Teh
Journal:  J Gastrointest Oncol       Date:  2015-04

Review 3.  Imaging for assessment of radiation-induced normal tissue effects.

Authors:  Robert Jeraj; Yue Cao; Randall K Ten Haken; Carol Hahn; Lawrence Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

Review 4.  Radiation-associated liver injury.

Authors:  Charlie C Pan; Brian D Kavanagh; Laura A Dawson; X Allen Li; Shiva K Das; Moyed Miften; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

5.  Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT.

Authors:  Judit Boda-Heggemann; Anika Jahnke; Mark K H Chan; Leila S Ghaderi Ardekani; Peter Hunold; Jost Philipp Schäfer; Stefan Huttenlocher; Stefan Wurster; Dirk Rades; Guido Hildebrandt; Frank Lohr; Jürgen Dunst; Frederik Wenz; Oliver Blanck
Journal:  Strahlenther Onkol       Date:  2018-02-05       Impact factor: 3.621

6.  Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy.

Authors:  Sam S Yoon; Thomas A Aloia; Alex B Haynes; Avinash Kambadakone; Harmeet Kaur; Jean-Nicolas Vauthey; Cristina R Ferrone; Andrew X Zhu; Jennifer Y Wo; Christopher Crane; Theodore S Hong
Journal:  Pract Radiat Oncol       Date:  2013-08-29

7.  Hepatotoxicity after liver irradiation in children and adolescents : results from the RiSK.

Authors:  Pascal Rösler; Hans Christiansen; Rolf-Dieter Kortmann; Carmen Martini; Christiane Matuschek; Frank Meyer; Christian Rübe; Thorsten Langer; Raphael Koch; Hans Theodor Eich; Normann Willich; Diana Steinmann
Journal:  Strahlenther Onkol       Date:  2014-12-09       Impact factor: 3.621

8.  Radiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments.

Authors:  P-M Wang; W-C Hsu; N-N Chung; F-L Chang; A Fogliata; L Cozzi
Journal:  Strahlenther Onkol       Date:  2013-02-20       Impact factor: 3.621

Review 9.  Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.

Authors:  Christopher H Crane; Eugene J Koay
Journal:  Cancer       Date:  2016-03-07       Impact factor: 6.860

Review 10.  Radiotherapeutic options for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Dong Soo Lee; Jinsil Seong
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.